“…Furthermore, many organotin(IV) derivatives have been found to possess anticancer activity in a variety of tumour cells and the structures of these organotin(IV) complexes are well characterized in the solid state [20,21]. Organotin(IV) complexes with Schiff bases, such as organotin(IV) esters of N-arylidene-amino acids, have also been shown to exhibit notable antitumour activity against human tumour cell lines [22], as well as fungicidal activity [23]. On the other hand, dialkyltin(IV) compounds have selective effects on lymphocytes [24][25][26], which can be used in cancer chemotherapy or to control other pathological effects.…”